Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells

about

Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells

Item

http://www.wikidata.org/entity/Q33566645

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@ast

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@en

Suberoylanilide hydroxamic aci ...... ceptor 1 in lung cancer cells.

@nl

type

Item

label

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@ast

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@en

Suberoylanilide hydroxamic aci ...... ceptor 1 in lung cancer cells.

@nl

prefLabel

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@ast

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@en

Suberoylanilide hydroxamic aci ...... ceptor 1 in lung cancer cells.

@nl

P1476

Suberoylanilide hydroxamic aci ...... eceptor 1 in lung cancer cells

@en

P2093

Bo Ra You

http://www.w3.org/2001/XMLSchema#string

Bo Ram Han

http://www.w3.org/2001/XMLSchema#string

Woo Hyun Park

http://www.w3.org/2001/XMLSchema#string

P2860

PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells

Epigenetic therapy of cancer with histone deacetylase inhibitors

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

Epigenetics of lung cancer

New and emerging HDAC inhibitors for cancer treatment

Epigenetic modulation with HDAC inhibitor CG200745 induces anti-proliferation in non-small cell lung cancer cells

The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes.

Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial.

Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo

Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment.

P304

17726-17737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14628

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28099148

http://www.w3.org/2001/XMLSchema#string

P921

TNF inhibitor

P932

5392281

http://www.w3.org/2001/XMLSchema#string